share_log

Ningbo Sanxing Medical ElectricLtd's (SHSE:601567) Solid Profits Have Weak Fundamentals

Ningbo Sanxing Medical ElectricLtd's (SHSE:601567) Solid Profits Have Weak Fundamentals

寧波三星醫療電氣有限公司(SHSE:601567)的穩定利潤與基本面相對較弱。
Simply Wall St ·  08/29 18:58

Ningbo Sanxing Medical Electric Co.,Ltd.'s (SHSE:601567) robust earnings report didn't manage to move the market for its stock. Our analysis suggests that this might be because shareholders have noticed some concerning underlying factors.

寧波三星醫療電器有限公司, Ltd. 's(上海證券交易所代碼:601567)強勁的收益報告未能推動其股票的市場走勢。我們的分析表明,這可能是因爲股東已經注意到了一些相關的潛在因素。

1724972336042
SHSE:601567 Earnings and Revenue History August 29th 2024
SHSE: 601567 收益和收入歷史記錄 2024 年 8 月 29 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

For anyone who wants to understand Ningbo Sanxing Medical ElectricLtd's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥340m worth of unusual items. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

對於任何想了解寧波三星醫療電氣有限公司超出法定數字的利潤的人來說,值得注意的是,在過去的十二個月中,從價值34000萬元人民幣的不尋常物品中獲得了法定利潤。雖然我們希望看到利潤增加,但當不尋常的物品做出重大貢獻時,我們往往會更加謹慎一些。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。假設這些不尋常的項目在本年度不會再次出現,因此我們預計明年的利潤將疲軟(也就是說,在業務沒有增長的情況下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Ningbo Sanxing Medical ElectricLtd's Profit Performance

我們對寧波三星醫療電氣有限公司盈利表現的看法

We'd posit that Ningbo Sanxing Medical ElectricLtd's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Ningbo Sanxing Medical ElectricLtd's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. Every company has risks, and we've spotted 1 warning sign for Ningbo Sanxing Medical ElectricLtd you should know about.

我們認爲,寧波三星醫療電氣有限公司的法定收益並不能完全反映當前的生產率,這是因爲這個很大的不尋常項目。因此,在我們看來,寧波三星醫療電氣有限公司的真正基礎盈利能力實際上可能低於其法定利潤。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。考慮到這一點,除非我們對風險有透徹的了解,否則我們不會考慮投資股票。每家公司都有風險,我們發現了你應該知道的寧波三星醫療電氣有限公司的1個警告標誌。

Today we've zoomed in on a single data point to better understand the nature of Ningbo Sanxing Medical ElectricLtd's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

今天,我們放大了單一數據點,以更好地了解寧波三星醫療電氣有限公司利潤的性質。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 「關注資金」,尋找內部人士正在買入的股票。因此,你可能希望看到這份擁有高股本回報率的公司的免費集合,或者這份內部所有權高的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論